Financial Performance & Guidance - H1 2025 revenue reached €3,086 million, showing a +0.9% organic growth[17, 199] - The company is on track to deliver upgraded guidance for FY25[15, 197] - H1 2025 EBITA was €246 million[17, 200] - Cash Flow From Operations (CFFO) for FY25 is guided to be greater than €500 million[20, 201] - Free Cash Flow (FCF) is expected to be above €370 million in FY25[44] Strategic Priorities & Initiatives - The company focuses on profitable contracts, activities, and retail customer segments[22, 27] - The company aims to improve profitability in Europe through cost reductions, including a redundancy plan affecting 250 employees and 150 external contractors[22, 31, 33] - The company is working to resolve outstanding tax issues, potentially avoiding close to €100 million in negative cash outlay[23, 37] - The company is enhancing in-house production capabilities with STUDIOCANAL, achieving global box office revenue of $213 million and local box office revenue of $136 million[52, 59, 61, 63] Subscriber Base - The company's subscriber base saw a slight decrease of -1.2%, with 25.7 million subscribers in H1 25 compared to 26.0 million in H1 24[208, 210]

29 July 2025 Q2 2025 Activities Report ASX/LSE - RSG 1 For personal use only This presentation contains information about Resolute Mining Limited (Resolute or the Company) and its activities that is current as at the date of this presentation unless otherwise stated. The information in this presentation remains subject to change without notice. This presentation has been prepared by Resolute and no party other than Resolute has authorised or caused the issue, lodgement, submission, despatch or provision of ...

Financial Performance - Total revenue decreased to £152.4 million, compared to £159.7 million in H1 2024[10, 11] - Adjusted operating profit decreased to £16.5 million, compared to £21.8 million in H1 2024[10, 11] - Adjusted operating profit margin decreased to 10.8%, compared to 13.7% in H1 2024[10, 11] - Adjusted basic EPS decreased to 3.4p, compared to 4.6p in H1 2024[10, 11] - Adjusted profit before tax decreased to £12.5 million, compared to £17.7 million in H1 2024[11] Regional Performance - EMEA revenue decreased to £82.0 million, compared to £89.4 million in H1 2024[31] - Americas revenue decreased to £50.0 million, compared to £51.3 million in H1 2024[34] - APAC revenue increased to £20.4 million, compared to £19.0 million in H1 2024[37] Strategic Initiatives - The company is targeting a medium-term adjusted operating margin of approximately 18%[25, 26] - The company is focused on market share growth and delivering on elements within its control[60] - The company is driving operational excellence to ensure enhanced levels of customer service[61] - The company is increasing its product offering in faster-growing end-markets, including selective bolt-on M&A[61]

2025 Interim Results 29 July 2025 Delivering income and value growth Successful first half of the year Strong financial performance and enhanced flexibility Delivering income and value growth Confidence in our prospects 2025 Interim Results 2 Successful first half of the Significant growth potential across our portfolio year Option 1 Strong operating and financial performance Growth in earnings, dividends, valuation and NTA Introduction of long-term, private capital Confidence in London's West End – Well-po ...

Q2 2025 Performance Highlights - Order intake increased by 6% year-on-year, and the order book increased by 7% year-on-year[11] - Sales grew by 1%, driven by growth in Personal Health, but partially offset by performance in Diagnosis & Treatment and Connected Care[11] - Adjusted EBITA margin increased by 130 bps to 12.4%[11] - Free cash flow increased from slightly positive to EUR 0.2 billion-0.4 billion, net of Respironics settlement[11] Order Book and Regional Performance - The order book is up 7% year-on-year, with an improved margin profile driven by recently launched innovations[16] - The order book accounts for approximately 40% of revenue[16] Financial Performance by Segment - Diagnosis & Treatment sales decreased by 1%[26] - Connected Care sales decreased by 1%[30] - Personal Health sales grew by 6%[38] Productivity and Outlook - Productivity initiatives delivered EUR 344 million year-to-date and are on track to deliver EUR 800 million in 2025[46] - The adjusted EBITA margin range is increased by 50 bps to 11.3%-11.8%[11]

Financial Performance - Science Group reported a record Adjusted Operating Profit (AOP), demonstrating resilience in a volatile market[5] - Group revenue increased to £57.2 million (H1-24: £53.7 million)[9, 16], while Adjusted Operating Profit reached £11.3 million (H1-24: £11.0 million)[9, 16] - Profit Before Tax significantly increased to £32.2 million (H1-24: £7.6 million)[7] and Statutory EPS increased to 55.3p (H1-24: 12.9p)[8] Investment in Ricardo plc - The investment in Ricardo plc generated a pre-tax investment gain of £24.0 million[9, 37] with a 74.2% Return on Investment[37] - The total investment in Ricardo was £32.4 million, realized for £58.0 million[37] - Tax liability on the Ricardo investment is estimated at £5.1 million[9, 37] Segment Performance - Professional Services revenue was £33.2 million (H1-24: £36.5 million) with an AOP of £7.9 million (H1-24: £8.8 million)[16, 22, 23] - Systems Division revenue increased to £23.7 million (H1-24: £16.8 million)[16] Cash Flow and Balance Sheet - Group cash increased to £82.0 million (H1-24: £38.8 million) and net funds to £70.3 million (H1-24: £26.4 million)[9, 21] - Cash generated from operations was £22.7 million (H1-24: £10.7 million)[21]

Financial Highlights - Rambus achieved record quarterly product revenue of $81 million[7], driven by a 43% year-over-year increase in Memory Interface Chips[8] - The company generated record cash from operations, reaching $94 million[7] - Total revenue for Q2 2025 was $172.2 million[10] Financial Performance & Outlook - Rambus' Q3 2025 non-GAAP outlook projects product revenue between $87 million and $93 million[15] - The company anticipates total operating costs between $94 million and $98 million for Q3 2025[15] - Licensing billings for Q3 2025 are expected to be between $58 million and $64 million[15] Balance Sheet Strength - Rambus' total cash and marketable securities reached $594.8 million in Q2 2025[12] - Total assets amounted to $1,467.8 million in Q2 2025[12] - Stockholders' equity stood at $1,228.0 million in Q2 2025[12]

Financial Performance - Net interest income decreased slightly by 0% from $122.8 million in Q3 2024 to $122.3 million in Q3 2025[8] - Noninterest income increased by 11% from $65.9 million in Q3 2024 to $73.4 million in Q3 2025[8] - Noninterest expense increased by 11% from $125.5 million in Q3 2024 to $139.3 million in Q3 2025[8] - Net income attributable to the parent company decreased by 6% from $44.9 million in Q3 2024 to $42.1 million in Q3 2025[10] - Earnings per diluted share increased by 2% from $1.78 in Q3 2024 to $1.81 in Q3 2025[10] Balance Sheet - Deposits decreased by 7% from $6,431.5 million in Q3 2024 to $6,005.2 million in Q3 2025[14] - Total loans and leases increased by 3% from $4,615.6 million in Q3 2024 to $4,743.3 million in Q3 2025[19] - Off-balance sheet custodial deposits averaged $732 million in Q3 2025, compared to $645 million in the prior year period[16] - Off-balance sheet custodial deposits were $431 million as of June 30, 2025, compared to $353 million as of June 30, 2024[16] Capital Allocation and Outlook - The company has liquidity sources totaling $2,652 million, including $953 million in cash and cash equivalents, $258 million in unpledged investment securities, and $200 million in Fed Discount Window Funds[22] - Fiscal Year 2025 EPS is projected to be $7.50-$7.80, assuming one rate cut in fiscal Q4 2025 and an effective tax rate of 16% to 20%[29] - Fiscal Year 2026 EPS is projected to be $8.25-$8.75, assuming no rate cuts during the year and an effective tax rate of 18% to 22%[29]

Financial Performance & Growth - Simpson has a customer-centric business model with above-market volume growth, high brand recognition, and a trusted reputation[7] - Since its IPO in 1994, Simpson has achieved a compound annual growth rate of approximately 15%[10, 12] - Simpson's EPS has grown from $0.14 to $7.60 between 1994 and 2024[13] - Approximately 52% of free cash flow has been returned to stockholders since 2021, exceeding the 35% target[7] - From 2020 to 2024, despite flat U S housing starts (approximately 14 million in both years), revenue increased from $125 billion to $223 billion, and operating income increased from $250 million to $430 million[46] - Simpson's North America operations have consistently outperformed U S housing starts, with an average of approximately 3% points above market growth historically and approximately 7% points above market growth more recently[43, 44] Market Position & Strategy - Simpson is a leader in structural solutions for wood connections with significant opportunities in all addressable markets[7] - The company's core addressable market includes wood connectors, ICS (Truss) & lateral systems ($38 billion market, $18 billion SSD share), fastening systems ($51 billion market, $05 billion SSD share), and concrete & steel connections ($28 billion market, $03 billion SSD share)[27] - Simpson has a broad portfolio of solutions, including over 10,000 standard and custom products for wood, concrete, and steel connections[30] - The company is focused on driving growth with digital solutions to make it easier to specify and order products[34] Capital Allocation & Future Ambitions - Simpson is well-positioned to execute its growth strategy with a demonstrated commitment to disciplined capital allocation[52] - The company's ambitions include maintaining an operating income margin of >20% and achieving EPS growth ahead of net revenue growth[66]

Q3 Fiscal Year 2025 Financial Performance - Revenue for Q3 FY'25 reached $2.042 billion, exceeding both the outlook range of $1.925 billion - $2.025 billion and the Q3 FY'24 revenue of $1.841 billion[11, 35] - Gross margin was 9.1%, surpassing the outlook range of 8.6% - 9.0%[11] - Operating margin was 5.7%, aligning with the high end of the outlook range of 5.4% - 5.8%[11] - Diluted EPS was $1.53, exceeding the outlook range of $1.35 - $1.45[11] Balance Sheet and Cash Flow - Cash and cash equivalents totaled $798 million as of June 28, 2025[21] - The company has substantial liquidity of approximately $1.7 billion, with no borrowings under the $800 million Revolver at quarter end[24] - Cash flow from operations was $201 million, with net CapEx of $33 million, resulting in free cash flow of $168 million[25] - The company repurchased 0.2 million shares for $13 million in Q3, and 1.4 million shares for $114 million year-to-date[25] Q4 Fiscal Year 2025 Outlook - Revenue is projected to be between $2.0 billion and $2.1 billion[28] - GAAP diluted EPS is expected to be in the range of $1.21 to $1.31, while non-GAAP diluted EPS is projected to be between $1.52 and $1.62[28] ZT Systems Acquisition - The acquisition of ZT Systems is on track to close near the end of the 2025 calendar year and is expected to generate $5 - $6 billion of net revenue on a run-rate basis[31] - The acquisition is expected to double Sanmina's net revenue within the next 3 years and be accretive to non-GAAP EPS in the first year after closing[31]